Stress and Resilience in Anesthesia Professionals (ResiStress)

The purpose of this study was to analyze the correlation between the resilience of anesthesia professionals and the stress measured during a simulation session.

Study Overview

• Status: Completed
• Conditions: Anaesthesiology; Resilience; High Fidelity Simulation; Stress, Professional
• Intervention / Treatment: Behavioral: SDNN measurement

Detailed Description

This trial will be carried out at the simulation center of the training institute for health professionals of the CHU Grenoble Alpes. Volunteer anesthesia professionals and students will perform a scenario simulating a pediatric laryngospasm during a surgical incision.

Each scenario will be performed by a medical and paramedical anesthesia pair and supervised by simulation trainers.

Stress and resilience measures will be taken at various times during the study. Participants will be debriefed at the end of the simulation.

The primary objective is to analyze the correlation between anesthesia professionals' resilience and measured stress.Secondary objectives are to study the association between: SDNN-measured stress and VAS-reported stress, age and SDNN-measured stress, CD RISC 10 resilience and PSS10-reported stress, CD RISC resilience and VAS-reported stress, the effect of experience on SDNN-measured stress, multiple correlation of the different secondary criteria.

secondary criteria.

• Study Type: Observational
• Enrollment (Actual): 34

Contacts and Locations

Study Locations

• France
  • Grenoble, France, 38000
    • University Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Anaesthetic teams composed with :

• 1 resident in anaesthesiology and critical care OR Anesthesiologist AND
• 1 anaesthetic nursing student OR 1 anaesthetic nurse graduated

Description

Inclusion Criteria:

- volunteer in anesthesia

Exclusion Criteria:

• Rhythm disorders
• Endocrine pathology
• High blood pressure
• Pregnancy or breastfeeding in progress
• Taking anti-inflammatory or psychotropic drugs that interfere with the heart rate
• Interruption of professional practice in anesthesia > 2 years

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Heart rate variability	Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants	during the laryngospasm (during 3 minutes at 6 minutes)
Resilience	Measurement of resilience by Connor-Davidson Resilience Scale 10 (CD RISC 10 from 0 to 40) in participants. A high score indicates better resilience.	5 days before scenario

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Self-reported stress	Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).	5 days before scenario
Self-reported stress	Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).	just Before the scenario (at 0 minute )
Self-reported stress	Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).	just after briefing (at 3 minutes)
Self-reported stress	Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).	just after the end of scenario (at 9 minutes)
Self-reported stress	Stress level self reported by participants on visual analogical scale (VAS from 0 to 100); One end of the scale represents the maximum conceivable symptom strength (i. e., 100%), the other end no symptoms whatsoever (i. e., 0%).	just after the debriefing (at 30 minutes)
Perceived Stress Scale	The Perceived Stress Scale (PSS10 from 10 To 50) measures the degree to which respondents feel their lives are unpredictable, uncontrollable, and overloaded. A high score indicates more stress.	5 days before scenario
Age of anesthesia professionals	Age of anesthesia professionals: (quantitative variable)	5 days before scenario
Experience in anesthesia:	Experience in anesthesia: number of years since the beginning of specialized training training (quantitative variable)	5 days before scenario
Pediatric experience:	Pediatric experience: qualitative variable (yes, no)	5 days before scenario
Pediatric laryngospasm experience	Pediatric laryngospasm experience: qualitative variable: (yes, no)	5 days before scenario
Heart rate variability	Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants	5 days before scenario (during 3 minutes)
Heart rate variability	Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants	Before the scenario (during 3 minutes)
Heart rate variability	Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants	during briefing (during 3 minutes at 0 minutes)
Heart rate variability	Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants	during the scenario before the laryngospasm (during 3 minutes at 3 minutes)
Heart rate variability	Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants	during the debriefing (3 minutes at 9 minutes)
Heart rate variability	Standard deviation of the average of RR intervals (SDNN in milliseconds) in participants	after the debriefing (3 minutes at 30 minutes)

Collaborators and Investigators

• Sponsor: University Hospital, Grenoble
• Investigators: Principal Investigator: Julien Picard, M.D, Ph.D., University Hospital, Grenoble

Study record dates

Study Major Dates

• Study Start (ACTUAL): June 18, 2021
• Primary Completion (ACTUAL): October 13, 2021
• Study Completion (ACTUAL): November 15, 2021

Study Registration Dates

• First Submitted: July 29, 2021
• First Submitted That Met QC Criteria: September 28, 2021
• First Posted (ACTUAL): October 11, 2021

Study Record Updates

• Last Update Posted (ACTUAL): March 18, 2022
• Last Update Submitted That Met QC Criteria: March 17, 2022
• Last Verified: March 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Behavioral Symptoms; Stress, Psychological; Occupational Diseases; Occupational Stress
• Other Study ID Numbers: IRB 02021 - 097

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No